Skip to content

Clinical evaluation of OR anti-abortion hair essence liquid to improve the scalp health of female androgenetic alopecia patients

Clinical evaluation of OR anti-abortion hair essence liquid to improve the scalp health of female androgenetic alopecia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105974
Enrollment
Unknown
Registered
2025-07-15
Start date
2024-06-30
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

androgenetic alopecia

Interventions

Trial Group:Apply OR Anti-hair Loss and Hair Growth Essence (Ningbo Tangyu Trading Co., Ltd.) topically, apply it to the entire scalp, 5 ml each time, once a day

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Female, age > = 18 years old and < = 40 years old, in good overall health; 2. Patients who meet the diagnostic criteria of AGA and have a Savin grade of D3-D6; 3. Scalp environmental problems, such as greasy hair, dandruff, scalp erythema, itching, odor and folliculitis and other symptoms; 4. Agree to follow the trial treatment protocol and visit plan, voluntarily enroll, and sign the informed consent form in writing; 5. No childcare plan and contraceptive measures during the study period and for 3 months after the last dose; 6. Willing to maintain the same hairstyle, hair color, and hair length at each follow-up visit, and willing to accept ornamentation.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, liver and kidney diseases and mental illness; 2. Those who cannot insist on follow-up or do not sign the informed consent form; 3. Those who have used systemic or topical drugs for the treatment of hair loss within 4 weeks; 4. Those with allergies, severe allergies to the ingredients of the test products; 5. Any other condition that, in the opinion of the investigator, is not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
The overall hair density in the target area;

Secondary

MeasureTime frame
The change in the ratio of terminal hairs to vellus hairs in the target area;The change in the average diameter of overall hairs in the target area;Hair Growth Assessment (Subject Self-assessment);Hair Growth Assessment (Investigator Assessment);Scalp Inflammation Changes;Scalp Environment Evaluation Indicators;

Countries

China

Contacts

Public ContactYang Dingquan

China-Japan Friendship Hospital

xyl66666@foxmail.com+86 181 0125 1552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026